...
首页> 外文期刊>The Journal of dermatology >Clinical efficacy of reserpine as 'add-on therapy' to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.
【24h】

Clinical efficacy of reserpine as 'add-on therapy' to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.

机译:利血平作为顽固性慢性特发性荨麻疹和荨麻疹性血管炎患者抗组胺药的“附加疗法”的临床疗效。

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic idiopathic urticaria (CIU) is a disabling affliction that considerably limits patients' daily activities and interferes with sleep. CIU and urticarial vasculitis (UV) is a disease spectrum,1 and CIU might be associated with UV.2 CIU is treated with antihistamines as a conventional therapy. Patients with urticaria refractory to antihistamines might be treated with cortico-steroid and cyclosporine.3 UV is usually treated with oral corticosteroids, colchicine or dapsone in combination with antihistamines. Recently, we reported the efficacy of reserpine for UV as well as CIU.2'4 Many years ago, reserpine had been used for urticaria pig-mentosa5 or chronic urticaria.6 However, reserpine has not been listed in the therapeutic guidelines of urticaria.7 There has been no strong evidence about reserpine therapy for CIU and UV.
机译:慢性特发性荨麻疹(CIU)是一种致残性疾病,极大地限制了患者的日常活动并干扰睡眠。 CIU和荨麻疹性血管炎(UV)是一种疾病谱,1和CIU可能与UV相关。2CIU作为常规治疗方法是使用抗组胺药治疗。耐抗组胺药的荨麻疹患者可以用皮质类固醇和环孢霉素治疗。3紫外线通常通过口服皮质类固醇,秋水仙碱或氨苯砜联合抗组胺药治疗。最近,我们报道了利血平对紫外线和CIU的疗效。2'4许多年前,利血平已被用于荨麻疹,猪-mentosa5或慢性荨麻疹。6但是,利血平尚未被列入荨麻疹的治疗指南中。 7没有关于利血平用于CIU和UV疗法的有力证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号